COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03191383
Brief Title: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

First Submitted : June 15, 2017
First Submitted that Met QC Criteria : June 15, 2017
First Posted : June 19, 2017

Last Update Submitted that Met QC Criteria : October 12, 2018
Last Update Posted : October 15, 2018